In the latest session, Processa Pharmaceuticals Inc (NASDAQ: PCSA) closed at $1.84 down -36.77% from its previous closing price of $2.91. In other words, the price has decreased by -$1.0700 from its previous closing price. On the day, 1277352 shares were traded.
Ratios:
For a deeper understanding of Processa Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.71 and its Current Ratio is at 7.71. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 07 ’24 when Young David bought 21,000 shares for $2.45 per share. The transaction valued at 51,526 led to the insider holds 79,387 shares of the business.
Young David bought 20,000 shares of PCSA for $50,504 on Feb 06 ’24. The Pres. Research & Development now owns 58,387 shares after completing the transaction at $2.53 per share. On Feb 01 ’24, another insider, Lin Patrick, who serves as the Chief Business – Strategy Off of the company, bought 1,500 shares for $2.40 each. As a result, the insider paid 3,600 and bolstered with 27,478 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 8.28M and an Enterprise Value of 3.73M.
Stock Price History:
Over the past 52 weeks, PCSA has reached a high of $18.00, while it has fallen to a 52-week low of $2.02. The 50-Day Moving Average of the stock is 2.3756, while the 200-Day Moving Average is calculated to be 6.5543.
Shares Statistics:
For the past three months, PCSA has traded an average of 1.65M shares per day and 621.45k over the past ten days. A total of 2.86M shares are outstanding, with a floating share count of 2.29M. Insiders hold about 19.75% of the company’s shares, while institutions hold 1.98% stake in the company. Shares short for PCSA as of Mar 15, 2024 were 40.25k with a Short Ratio of 0.02, compared to 95.66k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.36% and a Short% of Float of 2.66%.
Earnings Estimates
There are 0 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$7.2. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$7 and -$7 for the fiscal current year, implying an average EPS of -$7. EPS for the following year is -$6, with 1 analysts recommending between -$6 and -$6.
